Zhiling Zhou

1.2k total citations · 1 hit paper
50 papers, 861 citations indexed

About

Zhiling Zhou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Zhiling Zhou has authored 50 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Zhiling Zhou's work include Cardiac electrophysiology and arrhythmias (6 papers), MicroRNA in disease regulation (5 papers) and Immune cells in cancer (5 papers). Zhiling Zhou is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), MicroRNA in disease regulation (5 papers) and Immune cells in cancer (5 papers). Zhiling Zhou collaborates with scholars based in China, United States and Australia. Zhiling Zhou's co-authors include Zhi‐Xin Shan, Xi‐Yong Yu, Lin Shu-guang, Qiu‐Xiong Lin, Chunyu Deng, Jie-Ning Zhu, Youyi Zhang, Yong‐Heng Fu, Yangxin Li and Ronghua Zhu and has published in prestigious journals such as PLoS ONE, Gut and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhiling Zhou

49 papers receiving 846 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape

2024 80 citations Hai‐Kui Yang, Bo Dai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiling Zhou China	14	380	213	129	119	89	50	861
Haopeng Yang China	22	631 1.7×	109 0.5×	194 1.5×	161 1.4×	52 0.6×	41	1.3k
Pascal De Tullio Belgium	16	481 1.3×	160 0.8×	90 0.7×	139 1.2×	16 0.2×	43	1.1k
Xiaocong Pang China	18	525 1.4×	102 0.5×	134 1.0×	146 1.2×	51 0.6×	36	1.3k
Miao Li China	19	368 1.0×	117 0.5×	117 0.9×	96 0.8×	27 0.3×	58	986
Bongyong Lee United States	20	686 1.8×	412 1.9×	79 0.6×	53 0.4×	24 0.3×	49	1.0k
Feng Jin China	22	558 1.5×	164 0.8×	103 0.8×	252 2.1×	17 0.2×	73	1.3k
Vanessa Jacob Victorino Brazil	19	357 0.9×	159 0.7×	101 0.8×	255 2.1×	82 0.9×	34	950
Heon‐Woo Lee South Korea	15	279 0.7×	76 0.4×	67 0.5×	69 0.6×	28 0.3×	31	595

Countries citing papers authored by Zhiling Zhou

Since Specialization

Citations

This map shows the geographic impact of Zhiling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiling Zhou more than expected).

Fields of papers citing papers by Zhiling Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiling Zhou. The network helps show where Zhiling Zhou may publish in the future.

Co-authorship network of co-authors of Zhiling Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiling Zhou. A scholar is included among the top collaborators of Zhiling Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiling Zhou. Zhiling Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xuyan, Ying Pan, Ke Zhou, et al.. (2025). AMPK: An energy sensor for non-small cell lung cancer progression and treatment. Pharmacological Research. 212. 107592–107592. 4 indexed citations

Wang, Xuyan, Yuan Liao, Ruiqi Wang, et al.. (2025). Tribbles Pseudokinase 3 Converts Sorafenib Therapy to Neutrophil‐Mediated Lung Metastasis in Hepatocellular Carcinoma. Advanced Science. 12(13). e2413682–e2413682. 3 indexed citations

Lai, Fuming, Zhiling Zhou, Min Zhao, et al.. (2024). Surface energy prediction and Winterbottom morphology evolution analysis in Winterbottom construction on various crystal orientations using machine learning. Materials Science and Engineering B. 302. 117240–117240. 2 indexed citations

Zhou, Zhiling. (2023). Clinicopathological analysis of ovarian mucinous tumor. 4(7). 1 indexed citations

Wang, Ruiqi, et al.. (2023). Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology. 11. 1160544–1160544. 4 indexed citations

Wang, Chaoyue, Zhiling Zhou, Ping Xu, et al.. (2023). Coumarins from Jinhua Finger Citron: Separation by Liquid–Liquid Chromatography and Potential Antitumor Activity. Molecules. 28(19). 6917–6917. 3 indexed citations

Lin, Weijie, et al.. (2023). Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology. World Journal of Clinical Cases. 11(27). 6327–6343. 3 indexed citations

Lu, Ligong, Zhiling Zhou, Jinying Lu, et al.. (2022). PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut. 71(12). 2551–2560. 71 indexed citations

Zhou, Zhiling, Qiong Luo, Xinghua Hou, et al.. (2022). ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells. Cell Death and Disease. 13(2). 141–141. 14 indexed citations

10.

Yang, Mei, Yanhong Su, Danyu Du, et al.. (2021). C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma. Biochemical Pharmacology. 190. 114641–114641. 13 indexed citations

11.

He, Fazhong, Bao Sun, Ling Li, et al.. (2020). TRIB3 rs6037475 is a potential biomarker for predicting felodipine drug response in Chinese patients with hypertension. Annals of Translational Medicine. 8(7). 437–437. 7 indexed citations

12.

Zhou, Xiaohong, Weihua Lai, Xue Bai, et al.. (2020). Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease. Frontiers in Pharmacology. 11. 675–675. 3 indexed citations

13.

Liu, Lin, Hui Yang, Su‐Juan Kuang, et al.. (2019). Comparison of Ca<sup>2+</sup> Handling for the Regulation of Vasoconstriction between Rat Coronary and Renal Arteries. Journal of Vascular Research. 56(4). 191–203. 4 indexed citations

14.

Deng, Chunyu, Su‐Juan Kuang, Fang Rao, et al.. (2012). Effect of ranolazine on rat intrarenal arteries in vitro. European Journal of Pharmacology. 683(1-3). 211–216. 17 indexed citations

15.

Shan, Zhi‐Xin, et al.. (2008). [Plasmid-mediated miRNA-1-2 specifically inhibits Hand2 protein expression in H9C2 cells].. PubMed. 28(9). 1559–61, 1567. 2 indexed citations

16.

Deng, Chunyu, Xi‐Yong Yu, Su‐Juan Kuang, et al.. (2008). ELECTROPHYSIOLOGICAL EFFECTS OF KETAMINE ON HUMAN ATRIAL MYOCYTES AT THERAPEUTICALLY RELEVANT CONCENTRATIONS. Clinical and Experimental Pharmacology and Physiology. 35(12). 1465–1470. 7 indexed citations

17.

Zhou, Zhiling, Xi‐Yong Yu, Min Yang, et al.. (2008). Rapid and sensitive HPLC‐MS/MS method for pharmacokinetic assessment of ribavirin in healthy Chinese. Biomedical Chromatography. 22(12). 1409–1415. 12 indexed citations

18.

Shan, Zhi‐Xin, Qiaoli Lin, Min Yang, et al.. (2008). A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs. Molecular and Cellular Biochemistry. 323(1-2). 81–89. 19 indexed citations

19.

Zhou, Zhiling, Min Yang, Xi‐Yong Yu, et al.. (2007). A rapid and simple high‐performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies. Biomedical Chromatography. 21(10). 1045–1051. 23 indexed citations

20.

Zhou, Zhiling, et al.. (2006). Clinical and experimental studies on treatment of acute upper gastrointestinal haemorrhage with Huzhang Polygonum cuspidatum oral solution. Chinese Journal of Hospital Pharmacy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haopeng Yang Breakdown of academic impact, for papers by Pascal De Tullio Breakdown of academic impact, for papers by Xiaocong Pang Breakdown of academic impact, for papers by Miao Li Breakdown of academic impact, for papers by Bongyong Lee Breakdown of academic impact, for papers by Feng Jin Breakdown of academic impact, for papers by Vanessa Jacob Victorino Breakdown of academic impact, for papers by Heon‐Woo Lee